Vascular endothelium summary statement II: Cardiovascular disease prevention and control (Q36710486)

15 August 2017

Vascular endothelium summary statement II: Cardiovascular disease prevention and control (English)

1 reference

15 August 2017

0 references

1 reference

cardiovascular disease

1 reference

7

1 reference

15 August 2017

George A Mensah

1

0 references

W. Craig Hooper

3

object named as

W Craig Hooper

1 reference

15 August 2017

Una S Ryan

2

1 reference

15 August 2017

Michael M Engelgau

4

1 reference

15 August 2017

Allan D Callow

5

1 reference

15 August 2017

Gaston K Kapuku

6

1 reference

15 August 2017

21 November 2006

1 reference

15 August 2017

Vascular Pharmacology

1 reference

15 August 2017

46

1 reference

15 August 2017

5

1 reference

15 August 2017

318-320

1 reference

Fetal origins of coronary heart disease

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Endothelial dysfunction: does it matter? Is it reversible?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Aging-associated endothelial dysfunction in humans is reversed by L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Intrauterine undernutrition: expression and activity of the endothelial nitric oxide synthase in male and female adult offspring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Altered vascular function in fetal programming of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Shattuck lecture--clinical research to clinical practice--lost in translation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Endothelial dysfunction in hypercholesterolemia is reversed by a nutritional product designed to enhance nitric oxide activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Summary of the American Heart Association’s Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Mortality by cause for eight regions of the world: Global Burden of Disease Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Influence of smoking status on progression of endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Blood pressure and the global burden of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Production of the long pentraxin PTX3 in advanced atherosclerotic plaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

A strategy to reduce cardiovascular disease by more than 80%

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2006.10.019

10.1016/J.VPH.2006.10.019

7 January 2021

Identifiers

DOI

1 reference

15 August 2017

1 reference